MiR-29c-3p reduces bone loss in rats with diabetic osteoporosis via targeted regulation of Dvl2 expression.
- DOI
- 10.26355/eurrev_202101_24625
- Published
- 2021-01-01
- Container
- Eur Rev Med Pharmacol Sci
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.26355/eurrev_202101_24625,
title = {MiR-29c-3p reduces bone loss in rats with diabetic osteoporosis via targeted regulation of Dvl2 expression.},
author = {Cao Y and Qiu Y and Liu MX and Hu Y and Chen FW.},
year = {2021},
journal = {Eur Rev Med Pharmacol Sci},
doi = {10.26355/eurrev_202101_24625},
url = {https://doi.org/10.26355/eurrev_202101_24625}
}RIS
TY - JOUR TI - MiR-29c-3p reduces bone loss in rats with diabetic osteoporosis via targeted regulation of Dvl2 expression. AU - Cao Y AU - Qiu Y AU - Liu MX AU - Hu Y AU - Chen FW. PY - 2021 JO - Eur Rev Med Pharmacol Sci DO - 10.26355/eurrev_202101_24625 UR - https://doi.org/10.26355/eurrev_202101_24625 ER -
APA
Y, C., Y, Q., MX, L., Y, H., & FW., C. (2021). MiR-29c-3p reduces bone loss in rats with diabetic osteoporosis via targeted regulation of Dvl2 expression.. Eur Rev Med Pharmacol Sci. https://doi.org/10.26355/eurrev_202101_24625
Source records
- europe-pmc · retrieved 2026-09-27T05:59:06.121Z